Stemtech Corporation Expands Global Reach with New License Agreement in Africa
Stemtech Corporation Secures Exclusive Agreement to Propel Stemtech's Revolutionary Stem Cell Nutrition Across Six African NationsNAPLES, FL / ACCESSWIRE /...
Stemtech Corporation Secures Exclusive Agreement to Propel Stemtech's Revolutionary Stem Cell Nutrition Across Six African NationsNAPLES, FL / ACCESSWIRE /...
SPARKS, NV / ACCESSWIRE / January 31, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG): A US-based biotechnology company is pleased...
CHICAGO, IL / ACCESSWIRE / January 31, 2024 / Renalogic, the market leader in helping group benefits plans and their...
A new study from UCLA and MicroGenDX shows that bacteria may be one of the factors holding back male fertilityORLANDO,...
STONY BROOK, NY / ACCESSWIRE / January 31, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in...
ANN ARBOR, MI / ACCESSWIRE / January 31, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
THE WOODLANDS, TX., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical...
Kane will introduce its unique spray gel at the Boswick Burn and Wound Care SymposiumWINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE...
MIAMI, FL, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
SAN DIEGO and LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit"), a multi-asset, clinical-stage life...
Total number of voting rights and capital on January 31, 2024 January 31, 2024Company announcement No. 05 Referring to...
NORSE EIGHT clinical trial is being conducted under Special Protocol Assessment (SPA) from FDA to support expected resubmission of the...
MALVERN, Pa., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused...
FLORHAM PARK, N.J., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing...
WESTLAKE VILLAGE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing...
– Approval of IDE advances Company’s progress to make endoscopic gastroplasty an essential element of the primary obesity treatment algorithm...
Toronto, Ontario--(Newsfile Corp. - January 31, 2024) - Safe Supply Streaming Co. Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply"...
STOCKHOLM, SWEDEN / ACCESSWIRE / January 31, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...
PALO ALTO, CA / ACCESSWIRE / January 31, 2024 / Bioz, Inc., a leading AI software company based in Silicon...
MagnetOs ™ Granules becomes the third product in the MagnetOs portfolio to receive FDA clearance to market for interbody useKuros...